Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Oikawa

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Journal of Diabetes Investigation|July 13, 2021
Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Journal of Diabetes Investigation|September 6, 2024
Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of JapanTakeshi Horii, Yoichi Oikawa, Kasumi Kidowaki, et al.
Diabetology International|January 29, 2025
Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitusErika Mitsui, Atsushi Satomura, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|October 12, 2018
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practiceYoichi Oikawa, Takuma Kondo, Akira Shimada, et al.
Journal of Diabetes Investigation|May 9, 2022
Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes modelAkira Shimada, Kyoko Toda, Ikuo Inoue, et al.
Journal of Diabetes Investigation|September 20, 2022
Real-world risk of lower-limb amputation associated with sodium-glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in JapanGen Mizutani, Takeshi Horii, Yoichi Oikawa, et al.
BMJ Open Diabetes Research & Care|November 28, 2020
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
The Review of Diabetic Studies : RDS|October 7, 2009
The role of the CXCL10/CXCR3 system in type 1 diabetesAkira Shimada, Yoichi Oikawa, Yoshifumi Yamada, et al.
Endocrine Journal|July 8, 2016
CD4<sup>+</sup> T cell-dominant insulitis in acute-onset Type 1 diabetes mellitus associated with intraductal papillary mucinous adenomaKen Yajima, Yoichi Oikawa, Kentaro Ogata, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Thiazolidinediones may not reduce diabetes incidence in type 1 diabetesToshikatsu Shigihara, Yoshiaki Okubo, Yasuhiko Kanazawa, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Journal of Diabetes Investigation|July 13, 2021
Acute kidney injury in Japanese type 2 diabetes patients receiving sodium-glucose cotransporter 2 inhibitors: A nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Journal of Diabetes Investigation|September 6, 2024
Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large-scale claim database analysis of JapanTakeshi Horii, Yoichi Oikawa, Kasumi Kidowaki, et al.
Diabetology International|January 29, 2025
Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitusErika Mitsui, Atsushi Satomura, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|October 12, 2018
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practiceYoichi Oikawa, Takuma Kondo, Akira Shimada, et al.
Journal of Diabetes Investigation|May 9, 2022
Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes modelAkira Shimada, Kyoko Toda, Ikuo Inoue, et al.
Journal of Diabetes Investigation|September 20, 2022
Real-world risk of lower-limb amputation associated with sodium-glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in JapanGen Mizutani, Takeshi Horii, Yoichi Oikawa, et al.
BMJ Open Diabetes Research & Care|November 28, 2020
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
The Review of Diabetic Studies : RDS|October 7, 2009
The role of the CXCL10/CXCR3 system in type 1 diabetesAkira Shimada, Yoichi Oikawa, Yoshifumi Yamada, et al.
Endocrine Journal|July 8, 2016
CD4<sup>+</sup> T cell-dominant insulitis in acute-onset Type 1 diabetes mellitus associated with intraductal papillary mucinous adenomaKen Yajima, Yoichi Oikawa, Kentaro Ogata, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Thiazolidinediones may not reduce diabetes incidence in type 1 diabetesToshikatsu Shigihara, Yoshiaki Okubo, Yasuhiko Kanazawa, et al.
Pageof 11